Fda Regulation Of Compounded Glp1 Medications

Understanding FDA compounded GLP-1 regulation helps you make informed decisions about your treatment. Compounded medications exist in a specific legal framework that's different from brand-name drugs. Knowing how this framework works protects you from unsafe products and gives you confidence in the medication you receive.

Key Takeaways: - Understand what compounding means under federal law - 503A vs 503B Pharmacies: What's the Difference - The Shortage Exemption and What It Means - Learn how to verify your pharmacy is legitimate - Your Rights as a Patient

The rules can feel confusing. Let's break them down in plain language.

What Compounding Means Under Federal Law

Compounding is the process of creating a personalized medication for an individual patient based on a prescription from a licensed provider. It has been a part of pharmacy practice for centuries. The FDA recognizes compounding as a legitimate and necessary part of healthcare.

Under the Federal Food, Drug, and Cosmetic Act, compounding pharmacies operate under specific exemptions. They aren't required to go through the same approval process as brand-name drug manufacturers. This is because compounded medications are made for individual patients, not mass-produced for the general market.

There are two main categories of compounding pharmacies. Section 503A pharmacies compound individual prescriptions for specific patients. Section 503B facilities are outsourcing facilities that can produce larger batches without patient-specific prescriptions.

FormBlends works with licensed US-based 503A compounding pharmacies. This means every medication is prepared based on a prescription from your licensed provider, specifically for you. The pharmacy must follow current good manufacturing practices and use pharmaceutical-grade ingredients.

"The conversation about obesity needs to shift from willpower to biology. These medications work because obesity is a neuroendocrine disease, not a character flaw.") Dr. Fatima Cody Stanford, MD, MPH, Massachusetts General Hospital

Compounded medications aren't FDA-approved products. They contain compounded formulations of the active ingredient as brand-name medications, but the finished compound itself doesn't go through the FDA approval process. Your provider prescribes them based on your individual clinical needs.

503A vs 503B Pharmacies: What's the Difference

The distinction between 503A and 503B pharmacies matters for your safety and the legality of your medication.

View data table

Bar chart showing popular therapeutic peptides by use case: BPC-157 (88), TB-500 (82), Sermorelin (78), Ipamorelin (75), GHK-Cu (70)

Category	Clinical Interest Score	Detail
BPC-157	88	Tissue repair and gut healing
TB-500	82	Injury recovery
Sermorelin	78	Growth hormone support
Ipamorelin	75	Anti-aging and recovery
GHK-Cu	70	Skin and tissue repair

503A pharmacies are traditional compounding pharmacies. They operate under state pharmacy board oversight and must meet several requirements. They need a valid prescription for each patient. They must compound in response to a legitimate medical need. They can't advertise specific compounded drugs to consumers. And they must use ingredients that meet USP (United States Pharmacopeia) standards.

---

Free Download: Compounding Pharmacy Verification Checklist A step-by-step checklist to verify that your compounding pharmacy meets all federal and state requirements. Get yours free (we'll email it to you instantly.

[Download CTA Button]

---

503B outsourcing facilities operate under direct FDA oversight. They can produce larger quantities and don't always need patient-specific prescriptions. They must register with the FDA, comply with current good manufacturing practices, and submit to regular FDA inspections. They can supply medications to healthcare facilities.

For individual patients receiving , 503A pharmacies are the most common source. Your provider writes a prescription. The pharmacy compounds it. The medication is shipped directly to you.

The key legal requirement is that compounding must be done in response to a valid prescription from a licensed provider. This is why FormBlends connects you with who evaluate your health history before prescribing.

The Shortage Exemption and What It Means

Drug shortage status matters in the availability of compounded GLP-1 medications. When a brand-name drug is on the FDA's shortage list, compounding pharmacies have additional flexibility to prepare that medication.

Semaglutide was on the FDA shortage list for an extended period, which allowed 503A pharmacies to compound it more broadly. The market has evolved, and the availability of compounded versions depends on current shortage status and individual state regulations.

Tirzepatide came off the FDA shortage list in October 2024, which changed the market for that medication. But 503A pharmacies may still compound tirzepatide when there's a clinical need for a personalized formulation that differs from commercially available products.

The rules around shortage exemptions are complex and change over time. Your provider and pharmacy stay current on these regulations so you don't have to. What matters for you is that your medication comes from a legitimate source with a valid prescription.

For the latest information on , check with your provider.

How to Verify Your Pharmacy Is Legitimate

Not all compounding pharmacies operate at the same quality level. Here is how to verify that your pharmacy meets the standards you deserve.

First, check that the pharmacy holds a valid license from its state board of pharmacy. Every state has an online lookup tool where you can search by pharmacy name. A legitimate pharmacy will show an active, unrestricted license.

Second, confirm the pharmacy uses USP-grade ingredients. Ask directly. A reputable pharmacy will be transparent about its ingredient sourcing. The active pharmaceutical ingredient (API) should come from FDA-registered facilities.

Third, ask about third-party testing. Quality compounding pharmacies test their finished products for potency, sterility, and endotoxins. They should be willing to share certificates of analysis upon request.

Fourth, verify that the pharmacy requires a valid prescription. Any pharmacy willing to sell you a compounded GLP-1 medication without a prescription is operating outside the law. Walk away immediately.

If your medication comes through FormBlends, these verifications are already done for you. FormBlends partners only with pharmacies that meet strict quality and regulatory requirements. But it's always your right to ask questions and verify independently.

For more on evaluating , see our complete guide.

Your Rights as a Patient

As a patient receiving compounded medication, you have specific rights that protect you.

You have the right to know which pharmacy is compounding your medication. You have the right to contact that pharmacy directly with questions. You have the right to request certificates of analysis for your medication.

You have the right to report adverse events. If you experience an unexpected reaction, you can report it to the FDA's MedWatch program and to your state board of pharmacy. These reports help regulators identify problems and protect other patients.

You have the right to a licensed provider who evaluates your individual health needs before prescribing. No algorithm or quiz alone should determine whether you receive a prescription medication. A real provider must review your medical history and make a clinical decision.

You also have the right to switch providers or pharmacies at any time. If something feels wrong, trust your instincts. A legitimate will never pressure you into a treatment plan you're uncomfortable with.

Frequently Asked Questions

Are compounded GLP-1 medications legal?

Yes. Compounded medications are legal when prepared by a licensed pharmacy based on a valid prescription from a licensed provider. They must comply with applicable federal and state regulations. Compounding is recognized by the FDA as a legitimate pharmacy practice that serves patients with individualized medication needs.

Is compounded semaglutide the same as brand-name semaglutide?

Compounded semaglutide contains compounded formulations of the active ingredient as brand-name products. But it isn't FDA-approved as a finished product. The formulation, concentration, and inactive ingredients may differ. It's prepared by a licensed compounding pharmacy based on your provider's prescription for your specific needs.

How do I know if a compounding pharmacy is safe?

Check for an active state pharmacy license, ask about USP-grade ingredient sourcing, request third-party testing certificates, and confirm the pharmacy requires a valid prescription. Legitimate pharmacies are transparent about their processes and welcome patient questions.

Can compounding pharmacies make any medication they want?

No. Compounding pharmacies must follow specific rules about what they can compound. They generally can't compound medications that are importantly copies of commercially available products unless there's a documented clinical need for a different formulation or the drug is on the FDA shortage list.

Start your goals Today

Every transformation starts with a single step. Talk to a licensed FormBlends provider about whether this approach is right for you) consultations are free and confidential.

---

Medical References

1. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
2. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
3. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]

Sources &. References

1. Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections, United States, 2012. MMWR. 2012;61(41):839-842.
2. U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.
3. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
4. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
5. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
6. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
7. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563

Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.

Last updated: 2026-03-24